After coronary thrombolysis and reperfusion, What next?
- 31 October 1989
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 14 (4) , 837-849
- https://doi.org/10.1016/0735-1097(89)90454-3
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Safety and Tolerance Data from the Belgian Multicentre Study of Anisoylated Plasminogen Streptokinase Activator Complex versus Heparin in Acute Myocardial Infarction1Drugs, 1987
- Evidence for the Progressive Uptake of Anisoylated Plasminogen Streptokinase Activator Complex by Clots in Human Plasma in VitroDrugs, 1987
- Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agentsAmerican Heart Journal, 1986
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.Circulation, 1984
- Myocardial Salvage after Intracoronary Thrombolysis with Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1981